Non-Invasive Biomarker Panel May Help Classify Male Infertility Subtypes
Scientists have created a low-input fluid analysis method that identifies specific protein markers in seminal plasma to differentiate forms of azoospermia.
Key points
- Researchers developed EVGlyco, a workflow analyzing extracellular vesicle N-glycans from micro-volume biofluids.
- Specific protein biomarker panels differentiated obstructive azoospermia from nonobstructive azoospermia with high diagnostic accuracy.
- Selected N-glycan markers accurately distinguished three distinct subtypes of nonobstructive male infertility.
A new analytical testing approach using seminal plasma micro-samples may offer a non-invasive way to differentiate types of azoospermia, a severe form of male infertility characterized by a lack of sperm in ejaculated fluid, according to a study published in Nature Health Sciences by researchers from Nanjing Medical University, Southeast University, and Peking University.
The research team developed a molecular workflow named EVGlyco to isolate and examine site-specific sugar structures, known as N-glycans, attached to extracellular vesicle proteins in human biofluids. In an initial discovery evaluation using seminal plasma samples, the investigators identified 8,435 EV protein site-specific N-glycans.
Using targeted molecular validation, the study demonstrated that a biomarker panel consisting of MPO-N355-H6N2 and ACP3-N94-H5N4F1 distinguished obstructive azoospermia from nonobstructive azoospermia with an area under the curve value of 0.88. Additionally, markers CLU-N374-H10N9 and CLU-N374-H10N9F1 successfully separated three subtypes of nonobstructive azoospermia—hypospermatogenesis, maturation arrest, and Sertoli cell-only syndrome—achieving diagnostic accuracy scores of 0.86, 0.99, and 0.87, respectively.
What to know: While the technique shows diagnostic potential, these results represent an early-stage discovery cohort requiring further clinical validation in larger patient populations. Patients experiencing fertility issues should consult a medical professional for clinical evaluation and personal advice.
Source Nature Health Sciences — nature.com/articles/s41467-026-79570-x ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.